🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Risperidone Long-Acting injectable or oral antipsychotics

Found 20 matching trials

InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

N/A

International Observational Registry on Schizophrenia...

Status

Completed

Location

Multiple Locations

Start Date

2009-06

Trial ID

NCT01026285

Treatments Being Tested

Risperidone Long-Acting injectable or oral antipsychotics

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

PHASE1

The purpose of this study is to gather information about the steady-state p...

Status

Completed

Location

Multiple Locations

Start Date

2014-02

Trial ID

NCT02087579

Treatments Being Tested

Aripiprazole, oral formulation Olanzapine, oral formulation Paliperidone, oral formulation Paliperidone, LAI Quetiapine, oral formulation Risperidone, oral formulation Risperidone, LAI

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

PHASE3

In the proposed study 450 veterans with a primary diagnosis of schizophreni...

Status

Completed

Location

VA Medical Center, Tuscaloosa

Start Date

2006-09

Trial ID

NCT00132314

Treatments Being Tested

IM risperidone oral antipsychotic medication

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

PHASE4

The purpose of this study is to evaluate the effectiveness, safety and tole...

Status

Completed

Location

Multiple Locations

Start Date

2004-10

Trial ID

NCT00246259

Treatments Being Tested

Risperidone long-acting injection (LAI)Oral Antipsychotic

A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode

PHASE4

The purpose of this study is to evaluate the outcome of medication disconti...

Status

Completed

Location

Multiple Locations

Start Date

2006-04

Trial ID

NCT00378092

Treatments Being Tested

Oral risperidone Risperidone Long-Acting Injection (RLAI)Risperidone Long-Acting Injection (RLAI)

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

The purpose of this study is to evaluate the efficacy, tolerability and saf...

Status

Unknown

Location

Kwai Chung Hospital

Start Date

2004-10

Trial ID

NCT00563017

Treatments Being Tested

Long-acting Risperidone microspheres injection

A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

PHASE4

The purpose of this study is to assess the long-term symptomatic response (...

Status

Completed

Location

University Teaching Hospital of Butare(CHUB)

Start Date

2021-07-22

Trial ID

NCT04940039

Treatments Being Tested

Risperidone 3 mg Paliperidone Palmitate 50 mg eq.Paliperidone Palmitate 75 mg eq.Paliperidone Palmitate 100 mg eq.Paliperidone Palmitate 150 mg eq.Paliperidone Palmitate 175 mg eq.Paliperidone Palmitate 263 mg eq.Paliperidone Palmitate 350 mg eq.Paliperidone Palmitate 525 mg eq.

Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia

PHASE3

The purpose of this study is to demonstrate the effectiveness of paliperido...

Status

Completed

Location

Multiple Locations

Start Date

2007-03

Trial ID

NCT00589914

Treatments Being Tested

RISPERDAL CONSTA Paliperidone palmitate

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

PHASE4

The primary objective of this randomized trial was to investigate whether e...

Status

Completed

Location

Multiple Locations

Start Date

2005-11

Trial ID

NCT00216671

Treatments Being Tested

early initiation of treatment with Risperdal Consta routine initiation of treatment with Risperdal Consta

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

PHASE3

The purpose of this study is to investigate whether a long-acting injectabl...

Status

Completed

Location

Multiple Locations

Start Date

2004-10

Trial ID

NCT00216476

Treatments Being Tested

Aripiprazole Risperidone Long Acting Injectable (LAI)Quetiapine

Previous Next